BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6928250)

  • 1. Growth kinetics of mammary tumor 13762 in rats previously cured by chemotherapy.
    Braunschweiger PG; Schiffer LM
    J Natl Cancer Inst; 1980 Mar; 64(3):671-4. PubMed ID: 6928250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adriamycin on the cell kinetics of 13762 rat mammary tumors and implications for therapy.
    Braunschweiger PG; Schiffer LM
    Cancer Treat Rep; 1980; 64(2-3):293-300. PubMed ID: 7407764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic implications of cell kinetic changes after cyclophosphamide treatment in "spontaneous" and "transplantable" mammary tumors.
    Branunschweiger PG; Schiffer LM
    Cancer Treat Rep; 1978 May; 62(5):727-36. PubMed ID: 657158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell kinetic-directed sequential chemotherapy with cyclophosphamide and adriamycin in T1699 mammary tumors.
    Braunschweiger PG; Schiffer LM
    Cancer Res; 1980 Mar; 40(3):737-43. PubMed ID: 7471093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of surgical removal on the growth and kinetics of residual tumor.
    Gunduz N; Fisher B; Saffer EA
    Cancer Res; 1979 Oct; 39(10):3861-5. PubMed ID: 476622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma.
    Kreider JW; Bartlett GL
    J Natl Cancer Inst; 1985 Jul; 75(1):141-9. PubMed ID: 3859687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell population kinetics of fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse.
    Pavelic ZP; Porter CW; Allen LM; Mihich E
    Cancer Res; 1978 Jun; 38(6):1533-8. PubMed ID: 647669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of methylprednisolone on the cell kinetic response of C3H/HeJ mammary tumors to cyclophosphamide and adriamycin.
    Braunschweiger PG; Schiffer LM
    Cancer Res; 1979 Oct; 39(10):3812-5. PubMed ID: 476617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
    Janik P; Briand P; Hartmann NR
    Cancer Res; 1975 Dec; 35(12):3698-704. PubMed ID: 1192428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of serial passage in nude athymic mice on the growth characteristics and chemotherapy responsiveness of 13762 and R3230AC mammary tumor xenografts.
    Bogden AE; Kelton DE; Cobb WR; Gulkin TA; Johnson RK
    Cancer Res; 1978 Jan; 38(1):59-64. PubMed ID: 618583
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensity of proliferation and sensitivity of experimental tumors to the 1-methyl-1-nitrosourea.
    Emanuel NM; Ostrovskaya LA; Krutova TV
    Neoplasma; 1982; 29(5):597-603. PubMed ID: 7177250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivo.
    Goya L; Alexander DB; Webster MK; Kern FG; Guzman RC; Nandi S; Firestone GL
    Cancer Res; 1993 Apr; 53(8):1816-22. PubMed ID: 8467500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
    Fortner GW; Kuperman O; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
    Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
    Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing transplantation characteristics with serial in vivo passage of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1978 Oct; 38(10):3264-8. PubMed ID: 688216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis and necrosis occurring during different stages of primary and metastatic tumor growth of a rat mammary adenocarcinoma.
    Matsuda H; Strebel FR; Kaneko T; Stephens LC; Danhauser LL; Jenkins GN; Toyota N; Bull JM
    Anticancer Res; 1996; 16(3A):1117-21. PubMed ID: 8702222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse.
    Hosokawa M; Orsini F; Mihich E
    Cancer Res; 1975 Oct; 35(10):2657-62. PubMed ID: 1157040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA; Gladu J
    Cancer Res; 2002 Apr; 62(8):2390-7. PubMed ID: 11956102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of medroxyprogesterone acetate and doxorubicin on sublines of 13762 mammary adenocarcinoma in rats.
    Formelli F; Zaccheo T; Casazza AM; Bellini O; Di Marco A
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1211-21. PubMed ID: 6460631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.